PRNP and Creutzfeldt Jacob disease: Statins have been studied for the treatment of CJD initially because of their action destabilizing ‘lipid rafts’ – cholesterol-rich detergent-resistant membrane domains – that anchor PrPC to the cellular membrane, allowing their conversion and replication into PrPSc [65].